Obstetrics and Gynecology | Team led by Prof. Li Xiaoping Wins the Second Prize of the National Maternal and Child Health Science and Technology Award
李小平教授团队荣获“全国妇幼健康科学技术奖”二等奖

2023-11-12

On November 4, 2023, during the 5th China Maternal and Child Health Science and Technology Conference and Award Ceremony held in Beijing, a team led by Professor Li Xiaoping of the Obstetrics and Gynecology department from Peking University People's Hospital (PKUPH) was honored with the Second Prize of the National Maternal and Child Health Science and Technology Award.

Their project, titled "Innovative Strategies for Precision Diagnosis and Treatment of Recurrent Drug-Resistant Ovarian Cancer (复发耐药卵巢癌精准诊疗创新策略研究与临床应用)", received recognition as a significant achievement in scientific and technological advancement. This project, led by Professor Li Xiaoping and his team including Professor Wei Lihui, Professor Cui Heng, and Professor Wang Jianliu, in collaboration with Professor Pan Feng from Beihang University, represents years of exploration and collaboration resulting in groundbreaking innovations. Key contributors to this project include Li Xiaoping, Wei Lihui, Cui Heng, Wang Jianliu, Pan Feng, Zhu Honglan, Wang Yue, Shen Xiaoyan, Yang Yingchao, and Li Yi.

The "National Maternal and Child Health Science and Technology Award” is currently the most prestigious and influential science and technology award in the field domestically. It was established by the China Maternal and Child Health Association in 2014 to award the contributions of scientific workers and excellent achievements in technological innovation in the field of maternal and child health.

The project pioneered the development of unlabeled, high-throughput microfluidic technology combined with artificial intelligence-based digital holographic microscopy for rapid determination of chemotherapy drug sensitivity in single living cancer cells. It pioneered the multidisciplinary diagnosis and treatment of chemotherapy side effects in gynecologic tumors, including the coexistence of heart disease, kidney failure, cerebrovascular disease, and carriers of hepatitis B virus. It also conducted research on ovarian function preservation and the impact on offspring after pregnancy, promoting scientific research in precision medicine for gynecologic tumors.